These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18632632)

  • 1. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
    Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
    Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
    Nakashima A; Katagiri T; Tamura M
    J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins.
    Winkler DG; Sutherland MS; Ojala E; Turcott E; Geoghegan JC; Shpektor D; Skonier JE; Yu C; Latham JA
    J Biol Chem; 2005 Jan; 280(4):2498-502. PubMed ID: 15545262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation.
    Nakashima A; Tamura M
    Front Biosci; 2006 May; 11():1667-78. PubMed ID: 16368545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
    Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
    J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
    Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
    J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
    Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
    Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF.
    Fujita K; Janz S
    Mol Cancer; 2007 Oct; 6():71. PubMed ID: 17971207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells promote osteoblastic bone metastases through Wnts.
    Hall CL; Bafico A; Dai J; Aaronson SA; Keller ET
    Cancer Res; 2005 Sep; 65(17):7554-60. PubMed ID: 16140917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism.
    Fukuda T; Kokabu S; Ohte S; Sasanuma H; Kanomata K; Yoneyama K; Kato H; Akita M; Oda H; Katagiri T
    Differentiation; 2010 Jul; 80(1):46-52. PubMed ID: 20546990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells.
    Liu Z; Tang Y; Qiu T; Cao X; Clemens TL
    J Biol Chem; 2006 Jun; 281(25):17156-17163. PubMed ID: 16621789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression.
    Cho YD; Kim WJ; Yoon WJ; Woo KM; Baek JH; Lee G; Kim GS; Ryoo HM
    J Cell Physiol; 2012 Jun; 227(6):2287-96. PubMed ID: 22213482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.
    Thudi NK; Martin CK; Murahari S; Shu ST; Lanigan LG; Werbeck JL; Keller ET; McCauley LK; Pinzone JJ; Rosol TJ
    Prostate; 2011 May; 71(6):615-25. PubMed ID: 20957670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y; Rubin B; Bodine PV; Billiard J
    J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
    Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
    J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
    Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
    Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.
    Hall CL; Zhang H; Baile S; Ljungman M; Kuhstoss S; Keller ET
    Cancer Res; 2010 Dec; 70(23):9916-26. PubMed ID: 21098705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
    Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
    J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.